Michael Goldberg, Danong Chen | GenomeWeb

Michael Goldberg, Danong Chen

Michael Goldberg plans to resign from his position on the board of directors of Genomic Health as of the next annual stockholders meeting in May, according to a company filing with the US Securities and Exchange Commission last week.

Danong Chen has been elected as the new president and CEO of Theranostics Health. Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company that was acquired by Genentech in 2007.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.